These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17108193)

  • 1. Fetal nucleic acids in maternal body fluids: an update.
    Bianchi DW; Wataganara T; Lapaire O; Tjoa ML; Maron JL; Larrabee PB; Johnson KL
    Ann N Y Acad Sci; 2006 Sep; 1075():63-73. PubMed ID: 17108193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress.
    Maron JL; Bianchi DW
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):5-17. PubMed ID: 17299735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications.
    Wataganara T; Bianchi DW
    Ann N Y Acad Sci; 2004 Jun; 1022():90-9. PubMed ID: 15251945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester.
    Majer S; Bauer M; Magnet E; Strele A; Giegerl E; Eder M; Lang U; Pertl B
    Prenat Diagn; 2007 Dec; 27(13):1219-23. PubMed ID: 17968856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal nucleic acids in maternal plasma.
    Lo YM
    Ann N Y Acad Sci; 2008 Aug; 1137():140-3. PubMed ID: 18837938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating fetal DNA: its origin and diagnostic potential-a review.
    Bianchi DW
    Placenta; 2004 Apr; 25 Suppl A():S93-S101. PubMed ID: 15033315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free nucleic acids as potential markers for preeclampsia.
    Hahn S; Rusterholz C; Hösli I; Lapaire O
    Placenta; 2011 Feb; 32 Suppl():S17-20. PubMed ID: 21257079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free fetal nucleic acids in amniotic fluid.
    Hui L; Bianchi DW
    Hum Reprod Update; 2011; 17(3):362-71. PubMed ID: 20923874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA of placental origin is readily detectable in maternal plasma.
    Ng EK; Tsui NB; Lau TK; Leung TN; Chiu RW; Panesar NS; Lit LC; Chan KW; Lo YM
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4748-53. PubMed ID: 12644709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal diagnosis of aneuploidy using cell-free nucleic acids in maternal blood: promises and unanswered questions.
    Puszyk WM; Crea F; Old RW
    Prenat Diagn; 2008 Jan; 28(1):1-6. PubMed ID: 18022821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels.
    Wataganara T; Peter I; Messerlian GM; Borgatta L; Bianchi DW
    Obstet Gynecol; 2004 Sep; 104(3):545-50. PubMed ID: 15339767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allantoic fluid compositional changes during acute urine drainage in fetal sheep.
    Gilbert WM
    J Soc Gynecol Investig; 1999; 6(1):17-21. PubMed ID: 10065421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
    Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
    Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid.
    Zhong XY; Holzgreve W; Tercanli S; Wenzel F; Hahn S
    Arch Gynecol Obstet; 2006 Jan; 273(4):221-6. PubMed ID: 16189693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic technologies for prenatal diagnostics: advances and challenges ahead.
    Choolani M; Narasimhan K; Kolla V; Hahn S
    Expert Rev Proteomics; 2009 Feb; 6(1):87-101. PubMed ID: 19210129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma.
    Tsui NB; Lo YM
    Methods Mol Biol; 2008; 444():275-89. PubMed ID: 18425489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.
    Wright CF; Burton H
    Hum Reprod Update; 2009; 15(1):139-51. PubMed ID: 18945714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of foetal exposure to maternal cortisol using midtrimester amniotic fluid as a biomarker.
    Sarkar P; Bergman K; Fisk NM; O'Connor TG; Glover V
    Clin Endocrinol (Oxf); 2007 May; 66(5):636-40. PubMed ID: 17492950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester.
    Lapaire O; Volgmann T; Huang D; Hahn S; Holzgreve W; Zhong XY
    Obstet Gynecol; 2007 Dec; 110(6):1358-63. PubMed ID: 18055732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.